Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
POZEN INC (POZN)
|
Add to portfolio |
|
|
|
| Price: |
$2.71
| | Metrics |
| OS: |
32.8
|
M
| |
-60
|
% ROE
|
| Market cap: |
$88.8
|
M
| |
|
|
|
Net cash:
|
$37
|
M
| |
$1.13
|
per share
|
|
EV:
|
$51.8
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.2)
|
M
| |
|
|
|
EBIT
|
($1.2)
|
M
| |
|
|
| EPS |
($0.54)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 32.3 | 10.3 | 5.3 | 87.0 | 68.5 | 32.2 | 66.1 | 53.4 |
| Revenue growth | 213.2% | 93.0% | -93.8% | 26.8% | 113.0% | -51.3% | 23.7% | 295.4% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Gross profit | 32.3 | 10.3 | 5.3 | 86.9 | 68.5 | 32.2 | 66.1 | 53.4 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 10.1 | 17.2 | 19.0 | 21.8 | 23.8 | 17.8 | 12.3 | |
| Research and development | 5.7 | 9.9 | 11.9 | 23.0 | 22.7 | 22.4 | 61.9 | 40.0 |
| General and administrative | | | | | | | | 11.5 |
| EBIT | -3.6 | -16.8 | -25.5 | 42.2 | 22.1 | -8.0 | -8.1 | 2.0 |
| EBIT margin | -11.2% | -163.2% | -477.5% | 48.5% | 32.3% | -24.9% | -12.3% | 3.8% |
| Pre-tax income | -19.7 | -16.7 | -25.3 | 42.3 | 23.1 | -7.5 | -6.0 | 5.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.6 | 0.0 | 0.7 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 8.5% | 0.0% | 12.5% |
| Net income | 19.7 | -16.7 | -25.3 | 42.3 | 23.1 | -6.9 | -6.0 | 4.7 |
| Net margin | 60.9% | -161.9% | -472.7% | 48.7% | 33.7% | -21.3% | -9.0% | 8.7% |
| |
| Diluted EPS | $0.60 | ($0.55) | ($0.84) | $1.40 | $0.76 | ($0.23) | ($0.20) | $0.15 |
| Shares outstanding (diluted) | 32.8 | 30.4 | 30.1 | 30.3 | 30.2 | 29.8 | 29.8 | 30.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|